Pradaxa Reversal Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.
Reports Claim Drug Company Withheld Important Safety Information
The maker of a new anti-clotting medication may have withheld important safety information from regulators, according to several new reports.
FDA Compares Risks of Pradaxa and Warfarin
FDA research has taken a closer look at the risks of two medications commonly used to lower the risk for stroke and blood clots.
FDA Approves Pradaxa for Clotting Disorders
US regulators have approved a medication to treat and reduce two dangerous clotting disorders.
Dabigatran a Danger for Mechanical Valves?
Some patients with weak heart valves opt to get an artificial valve to improve heart function. These valves require lifelong anticlotting medication, but some medications may be more effective than others.
Does Stroke Rx Cause Excess Bleeding?
People with abnormal heart rhythms are at a higher risk of getting blood clots, which can cause a stroke. A blood-thinning medication may help. But some questions remain if these medications cause the bleeding.
Rx Busts Clots with Less Bleeding
Blood clots are very serious business that require treatment. But clot-busting medication can sometimes cause bleeding problems. Fortunately, a new medication may reduce bleeding side effects.